Development of in house elisas to detect antibodies to sars-cov-2 in infected and vaccinated humans by using recombinant s, s1 and rbd proteins

HIGHLIGHTS

• who: Aysun Yilmaz and colleagues from the SARS-Co, SARS-CoV- Department of Virology, Veterinary Faculty, Istanbul University-Cerrahpasa, Hadimkoy, Istanbul, Turkey have published the paper: Development of in House ELISAs to Detect Antibodies to SARS-CoV-2 in Infected and Vaccinated Humans by Using Recombinant S, S1 and RBD Proteins, in the Journal: Diagnostics 2022, 3085 of /2022/
• what: The aim of this study was to produce in-house ELISAs which can be used to determine SARS-CoV-2-specific antibody levels directed against the spike protein (S) the subunit of and the receptor . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.